Education
About Us
Working with TipRanks
Follow Us
Clarivate (CLVT)
NYSE:CLVT
CLVT Stock Chart & Stats
Day’s Range― - ―
52-Week Range$3.04 - $7.15
Previous CloseN/A
Volume814.08K
Average Volume (3M)3.85M
Market Cap
$2.57B
Enterprise Value$7.15B
Total Cash (Recent Filing)$362.60M
Total Debt (Recent Filing)$4.59B
Price to Earnings (P/E)―
Beta0.97
Next Earnings
Nov 11, 2025EPS Estimate
0.16Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.18
Shares Outstanding672,219,060
10 Day Avg. Volume3,353,236
30 Day Avg. Volume3,850,468
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market Cap2.78
Enterprise Value/Revenue2.86
Enterprise Value/Gross Profit4.33
Enterprise Value/Ebitda10.44
Forecast
1Y Price Target
$5.00Price Target Upside36.61% Upside
Rating ConsensusHold
Number of Analyst Covering7
Bulls Say, Bears Say
Bulls Say
Business Model RestructuringCLVT has restructured its business model to focus on recurring revenue streams, which is expected to provide more stability in revenue.
Product InnovationThe company is investing in product innovation, focusing on AI implementations to drive organic growth.
Bears Say
Market PressureA&G end-markets continue to face pressure from a reduction in U.S. federal government spending and increased constraints on higher education and research funding.
Risks To GrowthThe largest risks to CLVT's growth prospect include AI disintermediation, high leverage, and execution on its value creation plan.
Clarivate News
CLVT FAQ
What was Clarivate’s price range in the past 12 months?
Clarivate lowest stock price was $3.04 and its highest was $7.15 in the past 12 months.
What is Clarivate’s market cap?
Clarivate’s market cap is $2.57B.
When is Clarivate’s upcoming earnings report date?
Clarivate’s upcoming earnings report date is Nov 11, 2025 which is in 44 days.
How were Clarivate’s earnings last quarter?
Clarivate released its earnings results on Jul 30, 2025. The company reported $0.18 earnings per share for the quarter, beating the consensus estimate of $0.174 by $0.006.
Is Clarivate overvalued?
According to Wall Street analysts Clarivate’s price is currently Undervalued.
Does Clarivate pay dividends?
Clarivate does not currently pay dividends.
What is Clarivate’s EPS estimate?
Clarivate’s EPS estimate is 0.16.
How many shares outstanding does Clarivate have?
Clarivate has 672,219,060 shares outstanding.
What happened to Clarivate’s price movement after its last earnings report?
Clarivate reported an EPS of $0.18 in its last earnings report, beating expectations of $0.174. Following the earnings report the stock price went down -4.255%.
Which hedge fund is a major shareholder of Clarivate?
Currently, no hedge funds are holding shares in CLVT
Clarivate Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$5.00 (36.61% Upside)
$5.00 (36.61% Upside)
Blogger Sentiment
Neutral
CLVT Sentiment 50%
Sector Average 67%
Sector Average 67%
Hedge Fund Trend
Decreased
By 11.2M Shares
Last Quarter.
Last Quarter.
Insider Transactions
Bought Shares
Worth $617.1K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 6.6%
Last 30 Days ▼ 0.6%
Last 30 Days ▼ 0.6%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-45.20%
12-Months-Change
Fundamentals
Return on Equity
-8.18%
Trailing 12-Months
Asset Growth
-5.44%
Trailing 12-Months
Company Description
Clarivate
Clarivate Plc, an information services and analytics company, provides structured information and analytics for discovery, protection, and commercialization of scientific research, innovations, and brands. It offers Web of Science products and services, such as Web of Science, InCites, Journal Citation Reports, EndNote, ScholarOne, Converis, Publons, and Kopernio to organizations that plan, fund, implement, and utilize research; and Life Sciences products, including Cortellis and Newport Integrity for pharmaceutical and biotechnology companies to support research, market intelligence, and competitive monitoring in connection with the development and commercialization of new drugs. The company also provides Derwent products, which include Derwent Innovation, Techstreet, and IP Professional Services that enables its customers to evaluate the novelty of potential new products, confirm freedom to operate with respect to their product design, help them secure patent protection, assess the competitive technology landscape, and ensure that their products comply with required industry standards; CompuMark products, such as trademark screening, searching, and watching products and services for businesses and law firms; and MarkMonitor products, which helps enterprises to establish, manage, optimize, and protect their online presence. It serves government and academic institutions, life science companies, and research and development corporations in the Americas, the Middle East, Africa, Europe, and the Asia Pacific. The company was formerly known as Clarivate Analytics Plc and changed its name to Clarivate Plc in May 2020. Clarivate Plc is headquartered in London, the United Kingdom.
CLVT Company Deck
CLVT Earnings Call
Q2 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call highlighted strong organic growth, improved margins, and successful execution of the Value Creation Plan, particularly in AI-led innovations and high renewal rates. However, challenges such as a second quarter net loss and impacts from disposals, as well as constraints in university funding, were noted. Despite these challenges, the positive developments in growth and strategic execution suggest a favorable outlook.View all CLVT earnings summariesCLVT Stock 12 Month Forecast
Average Price Target
$5.00
▲(36.61% Upside)
Technical Analysis
Ownership Overview
7.10% Insiders
11.85% Mutual Funds
21.43% Other Institutional Investors
54.26% Public Companies and
Individual Investors